Case Report: CAR-T therapy for relapsed diffuse large B-cell lymphoma in a patient with pre-existing Parkinson’s disease—unfolding clinical challenges

Chimeric antigen receptor T-cell (CAR-T) therapy has transformed the outcomes for relapsed/refractory diffuse large B-cell lymphoma (DLBCL). However, immune effector cell–associated neurotoxicity syndrome (ICANS) remains a concern. Pre-existing neurological disorders such as Parkinson’s disease (PD)...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Anas Ibraheem, Helena Vincentelli, Andrea Kuhnl, Emil A Kumar, Andres Moya Davila, Piers EM Patten, Deborah Yallop, Reuben Benjamin, Charlotte Graham, Aaron Niblock, Robin Sanderson
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Frontiers Media S.A. 2026-02-01
Serie:	Frontiers in Oncology
Ämnen:	CAR-T therapy diffuse large B-cell lymphoma (DLBCL) immune effector cell–associated neurotoxicity syndrome (ICANS) multidisciplinary approach parkinsonism Parkinson’s disease (PD)
Länkar:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1759390/full
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!